Virginia 2026 Regular Session

Virginia Senate Bill SB745

Introduced
1/19/26  
Refer
1/19/26  
Report Pass
1/26/26  
Report Pass
2/5/26  
Engrossed
2/10/26  
Engrossed
2/10/26  
Refer
2/13/26  
Report Pass
2/19/26  
Enrolled
2/26/26  
Chaptered
4/6/26  
Passed
4/6/26  
Chaptered
4/6/26  

Caption

Health insurance; definitions, prohibited restrictions on in-network referrals.

Impact

The enactment of SB745 is expected to have a significant impact on the landscape of health insurance in Virginia. By eliminating restrictions on referrals, the bill enhances the ability of healthcare providers to collaborate and facilitate patient care. It ensures that patients can receive laboratory and pathology services from in-network entities without facing hurdles posed by their health plans, potentially improving health outcomes and reducing wait times for necessary tests and treatments. Additionally, the bill underscores the importance of maintaining a seamless flow of care within health plans.

Summary

SB745, a bill introduced in Virginia, aims to amend existing health insurance regulations by prohibiting restrictions on in-network referrals for clinical laboratories and pathology services. Specifically, it stipulates that health carriers shall not prevent in-network providers from referring enrollees to in-network clinical laboratories or pathology service providers, as long as such referrals comply with the applicable laws. This change is intended to simplify the referral process for patients and providers, ensuring that enrollees have access to necessary health services without unnecessary barriers.

Sentiment

The general sentiment surrounding SB745 appears to be positive among healthcare providers and patient advocacy groups who view it as a necessary measure to enhance patient care. Legislators expressed support for the bill, emphasizing its potential to mitigate barriers that have previously hindered enrollees from accessing required services. However, some concerns were raised regarding the balance between ensuring patient access and maintaining the financial viability of health insurance plans, which may need further discussion and assessment as the bill progresses through the legislative process.

Contention

While SB745 enjoys broad support, it does enter a complex debate about health administration practices and the balance of care versus cost. Critics of the bill might voice concerns that unrestricted referrals could lead to increased costs for health plans if not managed carefully. As such, the provisions of the bill may lead to discussions on how best to maintain affordability in healthcare while ensuring accessibility. These points of contention highlight a critical area of focus for lawmakers as they review and discuss the implications of the bill.

Companion Bills

No companion bills found.

Previously Filed As

VA SB735

Health insurance; denial of referral by direct primary care provider prohibited.

VA HB2392

Health insurance; pharmacy benefits managers, definition of "covered entity."

VA HB1670

Health insurance; cost-sharing for epinephrine injectors.

VA SB1311

Health insurance; pharmacy benefits managers, definition of "covered entity."

VA HB2525

Health insurance; electronic prior authorization, report.

VA HB2099

Health insurance; required provisions regarding prior authorization for health care services.

VA SB1215

Health insurance; required provisions regarding prior authorization for health care services.

VA HB2085

Health insurance; carrier business practices, method of payment for claims.

VA HB2773

Health insurance; cost-sharing, pharmacy benefits managers, compensation and duties, civil penalty.

VA SB925

Health insurance; carrier business practices, method of payment for claims.

Similar Bills

No similar bills found.